搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Targeted Oncology
12 小时
FDA Approves Cologuard Plus Stool DNA Test for Colorectal Cancer Screening
The noninvasive test provides a beneficial screening tool for patients 45 and older at average risk for colorectal cancer.
Targeted Oncology
14 小时
Genomic Profiling Offers a Personalized Approach to Breast Cancer Treatment
M. Michele Blackwood, MD, FACS, provided an overview of the significant advancements with personalized medicine with genomic ...
Targeted Oncology
16 小时
Adagrasib Demonstrates Superiority in KRAS G12C NSCLC
Robert Jotte, MD, PhD, discusses findings from the phase 3 KRYSTAL-12 study evaluating adagrasib in KRAS G12C-mutated NSCLC.
Targeted Oncology
18 小时
Beyond the Pink Ribbon: A Closer Look at Breast Cancer Progress
For Breast Cancer Awareness Month, Oranus Mohammadi, MD, discussed the remarkable progress made in improving survival rates ...
Targeted Oncology
1 天
FDA Approves Perioperative Nivolumab in Resectable NSCLC
The FDA has approved nivolumab plus chemotherapy as a neoadjuvant treatment for operable stage IIA to IIIB non–small cell ...
Targeted Oncology
1 天
Major Advances in Multiple Myeloma: A Recap of the 2024 IMS Meeting
International Myeloma Society Annual Meeting was a groundbreaking event that showcased the latest advancements in multiple ...
Targeted Oncology
1 天
Acalabrutinib Receives FDA Priority Review in Frontline MCL
Acalabrutinib, a BTK inhibitor, has shown promising results in treating mantle cell lymphoma, with the FDA granting it ...
Targeted Oncology
1 天
Assessing Targeted PET Imaging for Advanced Rectal Cancer
In an interview with Targeted Oncology, Jeffrey Wong, MD, discussed the potential and future directions of Cu 64 anti-CEA M5A ...
Targeted Oncology
2 天
September 2024 FDA Roundup: Key Decisions Drive Oncology Forward
On September 3, OBX-115, a novel TIL therapy, was granted FDA regenerative medicine advanced therapy (RMAT) designation in ...
Targeted Oncology
2 天
New ADC Shows Promise in Treating Relapsed Multiple Myeloma
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
Targeted Oncology
2 天
TMLI Trial Shows Potential in Relapsed/Refractory Leukemia
In an interview, Jeffrey Wong, MD, and Anthony Stein, MD, provided an in-depth discussion on a phase 2 trial of total marrow ...
Targeted Oncology
1 天
Innovative PET Imaging With Cu 64 Anti-CEA in Advanced Rectal Cancer
Jeffrey Wong, MD, discusses findings on the use of Cu 64 anti-CEA M5A as a PET imaging agent for advanced rectal cancer presented at the 2024 American Society for Radiation Oncology Annual Meeting.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈